1. Home
  2. MBOT vs VRCA Comparison

MBOT vs VRCA Comparison

Compare MBOT & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$1.87

Market Cap

114.9M

Sector

Health Care

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.85

Market Cap

137.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBOT
VRCA
Founded
2010
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.9M
137.3M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
MBOT
VRCA
Price
$1.87
$5.85
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$7.50
$17.00
AVG Volume (30 Days)
1.2M
29.2K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
60.27
N/A
EPS
N/A
N/A
Revenue
$116,887.00
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$119.77
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$1.60
$0.52
52 Week High
$4.62
$9.82

Technical Indicators

Market Signals
Indicator
MBOT
VRCA
Relative Strength Index (RSI) 46.54 42.22
Support Level $1.65 $5.32
Resistance Level $2.21 $6.48
Average True Range (ATR) 0.08 0.48
MACD 0.01 -0.01
Stochastic Oscillator 36.67 2.50

Price Performance

Historical Comparison
MBOT
VRCA

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: